This invention relates to novel 4-benzhydryloxy-tetraalkyl-piperidine derivatives of Formula (I), any of its stereoisomers or any mixture of its stereoisomers, or an N-oxide thereof, or a pharmaceutically acceptable salt thereof, wherein R
a
represents hydrogen or C
1-6
-alkyl; R
b
and R
c
independent of each other represent a phenyl group, which phenyl group is optionally substituted with one or more substituents independently selected from the group consisting of halo, trifluoromethyl, trifluoromethoxy, cyano, C
1-6
-alkoxy and methylenedioxo; R′, R″, R′″ and R″″ independent of each other represent C
1-6
-alkyl; and with the proviso that the compound is not 4-benzhydryloxy-1,2,2,6,6-pentamethyl-piperidine, useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
本发明涉及一种新型的4-苯甲酰氧基-四烷基-
哌啶衍
生物,其
化学式为(I),包括其任何立体异构体或其立体异构体的混合物,或其N-氧化物或其药学上可接受的盐,其中,R代表氢或C1-6-烷基;Rb和Rc独立地表示苯基,所述苯基可以选自卤素、三
氟甲基、三
氟甲氧基、
氰基、C1-6-烷氧基和亚甲基二氧基等基团中的一个或多个置换;R'、R"、R'"和R""独立地表示C1-6-烷基;但该化合物不是4-苯甲酰氧基-1,2,2,6,6-五甲基-
哌啶,有用作单胺神经递质再摄取
抑制剂。在其他方面,本发明涉及使用这些化合物的治疗方法以及包括本发明化合物的药物组合物。